The dysregulation of cellular apoptosis pathways has emerged as a critical
early event associated with the development of many types of human cancers.
Numerous viral and cellular oncogenes, aside from their inherent transform
ing properties, are known to induce programmed cell death, consistent with
the hypothesis that genetic defects are required to support tumor survival.
Here, we report that nuclear expression of the CREB-binding protein (CBP)/
p300-binding domain of the human T-cell lymphotropic virus type 1 (HTLV-1)
transactivator, Tax, triggers an apoptotic death-inducing signal during sho
rt-term clonal analyses, as well as in transient cell death assays. Coexpre
ssion of the antiapoptotic factor Bcl-2 increased serum stimulation; incuba
tion with the chemical caspase inhibitor z-Val-Ala-DL-Asp fluoromethylketon
e antagonized Tax-induced cell death. The CBP/p300-binding defective Tax mu
tants K88A and V89A exhibited markedly reduced cytotoxic effects compared t
o the wild-type Tax protein. Importantly, nuclear expression of the minimal
CBP/p300-binding peptide of Tax induced apoptosis in the absence of Tax-de
pendent transcriptional activities, while its K88A counterpart did not caus
e cell death. Further, Tax-mediated apoptosis was effectively prevented by
ectopic expression of the p300 coactivator. We also report that activation
of the NF-kappaB transcription pathway by Tax, under growth arrest conditio
ns, results in apoptosis that occurs independent of direct Tax coactivator
effects. Our results allude to a novel pivotal role for the transcriptional
coactivator p300 in determining cell fate and raise the possibility that d
ysregulated coactivator usage may pose an early barrier to transformation t
hat must be selectively overcome as a prerequisite for the initiation of ne
oplasia.